Cansortium Inc. (OTCMKTS:CNTMF – Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 31st, there was short interest totaling 23,111 shares, a drop of 58.5% from the July 15th total of 55,656 shares. Based on an average daily volume of 548,955 shares, the short-interest ratio is currently 0.0 days.
Cansortium Price Performance
OTCMKTS CNTMF traded down $0.00 during trading on Friday, reaching $0.02. 59,082 shares of the company’s stock were exchanged, compared to its average volume of 413,371. The business has a 50 day moving average price of $0.02 and a 200-day moving average price of $0.03. Cansortium has a fifty-two week low of $0.00 and a fifty-two week high of $0.08.
About Cansortium
Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.
Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.
Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.
Further Reading
- Five stocks we like better than Cansortium
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
